What is OptiProstate XTS?
OptiProstate XTS is an all natural prostate support supplement developed by Stop Aging Now. This product is designed to provide prostate support and ease symptoms associated with an enlarged prostate such as frequent urination, painful urination, and inflammation in the prostate.* OptiProstate XTS contains popular ingredients that are often included in comparable supplements such as Saw Palmetto and Pumpkin Seed Oil which help to support these claims of relieving symptoms.
Product Details:
Stop Aging Now recommends that its users consume one capsule daily for best results. Each bottle of OptiProstate XTS contains 30 capsules and so each bottle should last roughly one month when taken as directed. This product is affordably priced and can be purchased online directly through the manufacturer’s website. The manufacturer offers a few different bulk pricing options for this product that reduce the price per bottle as you purchase more. This company also offers an automatic shipment program which saves users even more money.
Pros:
- Bulk pricing options available
- Affordably priced
Cons:
- Lacks Vitamin E
- Lacks Zinc
Ingredients:
Omega-6 Fatty Acids, Omega-9 Fatty Acids, USPlus® Organic Saw Palmetto Extract, Organic Pumpkin Seed Oil
Top-Rated Prostate Support:
ViProsta
Which Product Do We Suggest?
#1 in Prostate Support – ViProsta
Official website: www.edenformulations.com
Coupon Code: HLDAILY (Save 10%)
Our studies and research have brought us to the conclusion that ViProsta uses high-quality ingredients that work. This is based on two factors: 1. Overwhelmingly positive customer feedback; and 2. Our own investigations into the grade of ingredients many of these products use.
This year, ViProsta – among others – were included in our study, and this supplement came in at the top in both regards. While there may be other formulas that suggested positive results during our research, we feel that ViProsta has shown the most benefits; making it HealthlineDaily’s Top Prostate Product of the year.
